Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2004 2
2005 1
2006 1
2007 1
2008 1
2009 3
2010 1
2012 1
2013 2
2014 1
2016 2
2018 1
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease.
Grattagliano I, Montezinho LP, Oliveira PJ, Frühbeck G, Gómez-Ambrosi J, Montecucco F, Carbone F, Wieckowski MR, Wang DQ, Portincasa P. Grattagliano I, et al. Among authors: montezinho lp. Biochem Pharmacol. 2019 Feb;160:34-45. doi: 10.1016/j.bcp.2018.11.020. Epub 2018 Nov 30. Biochem Pharmacol. 2019. PMID: 30508523 Review.
Therapeutic potential of metabotropic glutamate receptor modulators.
Hovelsø N, Sotty F, Montezinho LP, Pinheiro PS, Herrik KF, Mørk A. Hovelsø N, et al. Among authors: montezinho lp. Curr Neuropharmacol. 2012 Mar;10(1):12-48. doi: 10.2174/157015912799362805. Curr Neuropharmacol. 2012. PMID: 22942876 Free PMC article.
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
Majbour NK, Vaikath NN, van Dijk KD, Ardah MT, Varghese S, Vesterager LB, Montezinho LP, Poole S, Safieh-Garabedian B, Tokuda T, Teunissen CE, Berendse HW, van de Berg WD, El-Agnaf OM. Majbour NK, et al. Among authors: montezinho lp. Mol Neurodegener. 2016 Jan 19;11:7. doi: 10.1186/s13024-016-0072-9. Mol Neurodegener. 2016. PMID: 26782965 Free PMC article.
18 results